Sudarshan Pharma [SUDARSHAN] vs Navin Fluorine [NAVINFLUOR] Detailed Stock Comparison

Sudarshan Pharma

BSE

Navin Fluorine

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sudarshan Pharma wins in 7 metrics, Navin Fluorine wins in 10 metrics, with 0 ties. Navin Fluorine appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Sudarshan Pharma	Navin Fluorine	Better
P/E Ratio (TTM)	48.45	70.15	Sudarshan Pharma
Price-to-Book Ratio	5.85	9.46	Sudarshan Pharma
Debt-to-Equity Ratio	129.85	55.85	Navin Fluorine
PEG Ratio	N/A	0.54	N/A
EV/EBITDA	19.49	40.48	Sudarshan Pharma
Profit Margin (TTM)	3.83%	13.90%	Navin Fluorine
Operating Margin (TTM)	6.99%	23.65%	Navin Fluorine
EBITDA Margin (TTM)	6.99%	23.65%	Navin Fluorine
Return on Equity	12.14%	10.99%	Sudarshan Pharma
Return on Assets (TTM)	3.96%	5.97%	Navin Fluorine
Free Cash Flow (TTM)	$304.76M	$40.40M	Sudarshan Pharma
Dividend Yield	N/A	0.39%	N/A
1-Year Return	-79.44%	52.80%	Navin Fluorine
Price-to-Sales Ratio (TTM)	1.40	10.07	Sudarshan Pharma
Enterprise Value	$9.38B	$259.18B	Navin Fluorine
EV/Revenue Ratio	1.70	10.16	Sudarshan Pharma
Gross Profit Margin (TTM)	N/A	57.58%	N/A
Revenue per Share (TTM)	$23	$514	Navin Fluorine
Earnings per Share (Diluted)	$0.66	$71.43	Navin Fluorine
Beta (Stock Volatility)	1.25	0.23	Navin Fluorine

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Sudarshan Pharma vs Navin Fluorine Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Sudarshan Pharma	1.61%	8.72%	26.21%	8.39%	5.68%	-21.85%
Navin Fluorine	0.81%	-0.24%	0.74%	16.41%	28.62%	53.36%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Sudarshan Pharma	-79.44%	-37.69%	-37.69%	-37.69%	-37.69%	-37.69%
Navin Fluorine	52.80%	19.25%	135.76%	1,986.74%	8,408.96%	7,696.81%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Sudarshan Pharma (SUDARSHAN): View Full Stock Overview

Navin Fluorine (NAVINFLUOR): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Sudarshan Pharma vs Navin Fluorine

Metric	SUDARSHAN	NAVINFLUOR
Market Information
Market Cap i	₹7.70B	₹257.00B
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	288,800	76,504
90 Day Avg. Volume i	368,933	123,743
Last Close	₹34.77	₹5,030.50
52 Week Range	₹24.69 - ₹452.70	₹3,160.40 - ₹5,444.00
% from 52W High	-92.32%	-7.60%
All-Time High	₹452.70 (Sep 30, 2024)	₹5,444.00 (Jul 31, 2025)
% from All-Time High	-92.32%	-7.60%
Growth Metrics
Quarterly Revenue Growth	0.46%	0.39%
Quarterly Earnings Growth	N/A	1.29%
Financial Health
Profit Margin (TTM) i	0.04%	0.14%
Operating Margin (TTM) i	0.07%	0.24%
Return on Equity (TTM) i	0.12%	0.11%
Debt to Equity (MRQ) i	129.85	55.85
Cash & Liquidity
Book Value per Share (MRQ)	₹5.46	₹529.59
Cash per Share (MRQ)	₹0.09	₹99.90
Operating Cash Flow (TTM) i	₹8.46M	₹4.60B
Levered Free Cash Flow (TTM) i	₹159.55M	₹2.89B
Dividends
Last 12-Month Dividend Yield i	N/A	0.39%
Last 12-Month Dividend i	N/A	₹19.00

Valuation & Enterprise Metrics Analysis: Sudarshan Pharma vs Navin Fluorine

Metric	SUDARSHAN	NAVINFLUOR
Price Ratios
P/E Ratio (TTM) i	48.45	70.15
Forward P/E i	N/A	41.46
PEG Ratio i	N/A	0.54
Price to Sales (TTM) i	1.40	10.07
Price to Book (MRQ) i	5.85	9.46
Market Capitalization
Market Capitalization i	₹7.70B	₹257.00B
Enterprise Value i	₹9.38B	₹259.18B
Enterprise Value Metrics
Enterprise to Revenue i	1.70	10.16
Enterprise to EBITDA i	19.49	40.48
Risk & Other Metrics
Beta i	1.25	0.23
Book Value per Share (MRQ) i	₹5.46	₹529.59

Financial Statements Comparison: Sudarshan Pharma vs Navin Fluorine

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	SUDARSHAN	NAVINFLUOR
Revenue/Sales i	N/A	₹7.25B
Cost of Goods Sold i	N/A	₹3.08B
Gross Profit i	N/A	₹4.18B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	N/A	₹1.72B
EBITDA i	N/A	₹2.21B
Pre-Tax Income i	N/A	₹1.55B
Income Tax i	N/A	₹379.40M
Net Income (Profit) i	N/A	₹1.17B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	SUDARSHAN	NAVINFLUOR
Cash & Equivalents i	₹5.51M	₹196.80M
Total Current Assets i	₹3.35B	₹15.89B
Total Current Liabilities i	₹2.60B	₹9.15B
Long-Term Debt i	₹104.60M	₹10.67B
Total Shareholders Equity i	₹1.31B	₹26.26B
Retained Earnings i	N/A	₹23.27B
Property, Plant & Equipment i	₹200.50M	₹25.97B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	SUDARSHAN	NAVINFLUOR
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	SUDARSHAN	NAVINFLUOR
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	288,800	76,504
Average Daily Volume (90 Day) i	368,933	123,743
Shares Outstanding i	240.66M	49.59M
Float Shares i	78.34M	34.84M
% Held by Insiders i	0.75%	0.29%
% Held by Institutions i	0.00%	0.41%

Dividend Analysis & Yield Comparison: Sudarshan Pharma vs Navin Fluorine

Metric	SUDARSHAN	NAVINFLUOR
Last 12-Month Dividend i	N/A	₹19.00
Last 12-Month Dividend Yield i	N/A	0.39%
3-Year Avg Annual Dividend i	N/A	₹16.33
3-Year Avg Dividend Yield i	N/A	0.15%
3-Year Total Dividends i	N/A	₹49.00
Ex-Dividend Date	N/A	Jul 04, 2025

Sudarshan Pharma [SUDARSHAN] vs Navin Fluorine [NAVINFLUOR] Detailed Stock Comparison